A cell permeable peptide inhibitor of NFAT inhibits macrophage cytokine expression and ameliorates experimental colitis

Keyphrases

• Macrophage Cytokines 100%
• Peptide Inhibitor 100%
• Cytokine Expression 100%
• Cell-penetrating Peptide 100%
• Experimental Colitis 100%
• Nuclear Factor of Activated T Cells 100%
• 11R-VIVIT 50%
• Macrophages 30%
• IL-12p40 30%
• Gene Expression 20%
• Interleukin-12 (IL-12) 20%
• Inhibitory Peptide 20%
• Cell Permeable 20%
• IL-10 Knockout Mice 20%
• Colitis 20%
• Bone Marrow-derived Macrophages 20%
• Therapeutic Strategies 10%
• Protein Expression 10%
• Transcriptional Regulator 10%
• T Cell Activation 10%
• MRNA Expression 10%
• Specific Genes 10%
• Therapeutic Potential 10%
• Inflammatory Bowel Disease 10%
• Supernatant 10%
• Murine Macrophages 10%
• Nuclear Translocation 10%
• Tacrolimus 10%
• Interleukin-23 (IL-23) 10%
• Inflammatory Pathways 10%
• IL-10 Expression 10%
• Non-immune 10%
• Nuclear Binding 10%
• Piroxicam 10%
• Explant Culture 10%
• T-cell Cytokines 10%
• T Cell Inhibitors 10%
• Selective Blocking 10%
• T Cell Biology 10%
• Colon Explants 10%
• T Cell Inhibition 10%

Immunology and Microbiology

• Cytokine 100%
• Macrophage 100%
• Colitis 100%
• Transcription Factor NFAT 100%
• Peptides 100%
• Interleukin 10 30%
• Gene Expression 20%
• Secretion (Process) 20%
• T Cell 20%
• Bone Marrow-Derived Macrophage 20%
• Promoter Region 10%
• Cell Function 10%
• Tumor Necrosis Factor 10%
• Immunocompetent Cell 10%
• Colon 10%
• Protein Expression 10%
• Inflammatory Bowel Disease 10%
• Supernatant 10%
• Tacrolimus 10%
• Explant 10%